Frontier Medicines

Print and Online Coverage

  • Wall Street Journal – Biotech entrepreneur Chris Varma scores $67 million for Frontier Medicines
  • San Francisco Business Times – How an entrepreneur with UC technology is on the trail toward the ‘undruggable’
  • Silicon Valley Business Journal – How an entrepreneur with UC technology is on the trail toward the ‘undruggable’
  • BioCentury – Frontier aims for previously unreachable ‘hot spot’ targets with $67M series A
  • Fierce Biotech – Frontier Medicines launches with $67M and biotech veteran Varma as CEO
  • Science Business – Company launches attacking cancer proteins, lands $67M
  • EndPointsNews – Chris Varma unveils MPM’s latest start-up – eying ‘undruggable’ cancer targets and powered by machine learning, $67M
  • Chemical and Engineering News – Frontier Medicines launches with $67 million in funding
  • Bio Space – Frontier Medicines closes $67 Million Series A, Will Focus on Chemoproteomics
  • Finsmes – Frontier Medicines Closes $67M series A Financing
  • PE Hub Network – Frontier Medicines picks up $67 mln
  • The Pharma Letter – Frontier Medicines launches with $67 million financing
  • Axios – Top of the Morning/Venture Capital Deals: Frontier Medicines
  • MedCity News – Frontier Medicines launches with $67M Series A, hopes to go after ‘undruggable’ targets
  • Silicon Valley Business Journal – The Funded: Led by three megarounds, Bay Area startups haul in $800M in venture funding
  • BioSpace – Latham & Watkins Advises Frontier Medicines in $67 Million Series A Financing for Development of Novel Medicines
  • BioToday – Japan, article is behind a paywall and is not included in the clips section at the end of this report
  • CYY123 – China, this article was republished on several media websites. The translation of this article is included in the clips below
  • Wall Street Journal – VC Daily: Midyear Fundraising Bounty | Fifty Years Is Refueling | VC: The History
  • Wall Street Journal – Life Sciences Venture Firm MPM Capital Seeks $200 Million Oncology Fund
  • Investank – Latham & Watkins Advises Frontier Medicines in $67 Million Series A Financing for Development of Novel Medicines
  • MedCity News – StartUPDATES: The latest healthcare startup news from MedCitizens
  • MedCity News – RA Capital Management closes $308M venture capital fund
  • MedCity News – Revolution Medicines secures $100M equity round, aiming for hard-to-reach oncology targets
  • MedCity News – Kronos Bio bags $105M in Series A round for platform technology
  • BioPharm Guy – Frontier Medicines
  • BioPortfolio – Frontier Medicines gets $67mm in Series A round
  • Fierce Biotech – Chutes & Ladders–Frontier Medicines launches with biotech vet as CEO
  • Global University Venturing – Frontier faces down $67m
  • CB Insights – This Week In AI: Apple and Uber Acquire AV Startups, CMU Partners With Argo AI, MIT Researchers Turn Proteins Into Music
  • FierceBiotech – Frontier Medicines bolsters leadership team with new CSO, tech hires
  • Med City News – Amgen cancer drug with ‘undruggable’ target shows more progress
  • Biocentury – R&D chief leaving Adaptimmune; plus Frontier Medicines builds out team and more
  • Wall Street Journal – VC Daily: ThredUp Deal Near; Impossible Boosts Production; & more
  • Fierce Biotech – Chutes & Ladders
  • Exome – Frontier Medicines Adds Kevin Webster, Johannes Hermann to C-Suite
  • Exome – Bio Roundup
  • PE Hub Network – Frontier Medicines adds three to executive team
  • PE Hub Network – On the move: Ares hires Joel Holsinger as co-head of alternative credit
  • Becker’s – Healthcare AI reached record-high $846M funding in Q2
  • Progress in Lending Association – Early Stage Funding Rounds Accounted For 75.6% Of Total Investment
admin

Leave a comment

Your email address will not be published. Required fields are marked *